Narrow-band Ultraviolet B-based Anti-ageing and Life extension therapy: Narrow-band Ultraviolet B increases CHIP levels, increases monoubiquitylation of insulin receptor (INSR), decreases INSR protein levels and enhances lifespan via down regulation of its target gene, 2/June/2017, 11.51 pm

Narrow band ultraviolet B-based therapy for Inflammatory bowel disease: Narrow band ultraviolet B promotes NFKB-p50/p65 dimer formation, induces inflammatory gene expression downstream of RelA/p65, inhibits colonic pathogenesis, and stalls the progression of inflammatory bowel disease and colitis via down regulation of its target gene, 2/June/2017, 11.45 pm
June 2, 2017
Natural product-derived Lifespan extension therapy: Isoliquiritigenin(ILQ), isolated from Licorice, prolongs mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 3/June/2017, 12.03 am
June 2, 2017
Show all

Introduction: What they say

A study from Institute for Cell Biology, University of Bonn, Ulrich-Haberland Str.  Bonn, Germany; and Institute for Genetics and CECAD Research Center, University of Cologne, Joseph-Stelzmann Str. Cologne, Germany shows that “The Ubiquitin Ligase CHIP Integrates Proteostasis and Aging by Regulation of Insulin Receptor Turnover.” This research paper was published, in the 20 April 2017 issue of the journal “Cell” [One of the best research journals in Biology with an I.F of 28 plus], by Prof. Hoppe T,Tawo R and others.


What we say:

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Narrow-band Ultraviolet B-based Anti-ageing and Life extension therapy: Narrow-band Ultraviolet B increases CHIP levels, increases monoubiquitylation of insulin receptor (INSR), decreases INSR protein levels and enhances lifespan via down regulation of its target gene


What is known?

Prof. Hoppe T’s research team has recently shown that knocking down CHIP gene in mice results in a) increased protein levels of insulin receptor (INSR); and b) reduced lifespan. Further, they have shown that CHIP targets INSR for mono ubiquitylation and degradation, while its ability to degrade INSR is compromised upon proteotoxic stress and during ageing, as CHIP is directed toward disposal of misfolded proteins rather than degrade the INSR.


From Research findings to Therapeutic opportunity:

This study suggests, for the first time, a Narrow-band Ultraviolet B-based anti-ageing therapy.

Narrow-band Ultraviolet B, by decreasing the expression of its target gene, it may increase the levels of CHIP (carboxy terminus of Hsc70 interacting protein). Thereby, it may: (1) increase CHIP-assisted proteolysis; (2) increase mono ubiquitylation and degradation of INSR; (3) inhibit the insulin and IGF1 signaling pathway; and (4) enhance longevity (Fig1).

Figure 1. Mechanistic insights into how Celastrol induces CHIP expression and extends lifespan

Thus, Narrow-band Ultraviolet B-based therapy may be used to suppress age-associated overall physiological decline and improve health/life span.


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How  Narrow-band Ultraviolet B irradiation decreases the levels of INSR and promotes longevity

Amount:$500#

* Research cooperation


Citation:

Web: http://genomediscovery.org or http://newbioideas.com

 

Citation: Boominathan, L., Narrow-band Ultraviolet B-based Anti-ageing and Life extension therapy: Narrow-band Ultraviolet B increases CHIP levels, increases monoubiquitylation of insulin receptor (INSR), decreases INSR protein levels and enhances lifespan via down regulation of its target gene, 2/June/2017, 11.51 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Comments are closed.